Paper41897503
2-Methoxystypandrone from Polygonum cuspidatum Rejuvenates Senescence by Reducing Mitochondrial ROS.
Yoon JH and 13 others. Antioxidants (Basel), 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. 2-Methoxystypandrone from Polygonum cuspidatum Rejuvenates Senescence by Reducing Mitochondrial ROS. Papers, record 41897503. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41897503
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- 2-Methoxystypandrone from Polygonum cuspidatum Rejuvenates Senescence by Reducing Mitochondrial ROS.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| RS-2023-KH140816 | the Ministry of Health & Welfare, Republic of Korea | PubMed |
Source PubMed
References85
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19910238 | Mitochondrial-targeted fluorescent probes for reactive oxygen species. | Curr Opin Chem Biol | 2010 | https://conductscience.org/library/papers/19910238 | PubMed |
| 2 | 28654243 | Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications. | Chem Rev | 2017 | https://conductscience.org/library/papers/28654243 | PubMed |
| 3 | 35093936 | Targeting regulation of ATP synthase 5 alpha/beta dimerization alleviates senescence. | Aging (Albany NY) | 2022 | https://conductscience.org/library/papers/35093936 | PubMed |
| 4 | 31379458 | Hallmarks of senescence and aging. | Biochem Med (Zagreb) | 2019 | https://conductscience.org/library/papers/31379458 | PubMed |
| 5 | 22363165 | A simple assay method for melanosome transfer. | Ann Dermatol | 2012 | https://conductscience.org/library/papers/22363165 | PubMed |
| 6 | 37997995 | The Skin and Inflamm-Aging. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37997995 | PubMed |
| 7 | 37239882 | Protective Effects of Cirsilineol against Lipopolysaccharide-Induced Inflammation; Insights into HO-1, COX-2, and iNOS Modulation. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37239882 | PubMed |
| 8 | 33293849 | Reactive Oxygen Species: Drivers of Physiological and Pathological Processes. | J Inflamm Res | 2020 | https://conductscience.org/library/papers/33293849 | PubMed |
| 9 | 35203350 | Mitofusin-2 Negatively Regulates Melanogenesis by Modulating Mitochondrial ROS Generation. | Cells | 2022 | https://conductscience.org/library/papers/35203350 | PubMed |
| 10 | 38138627 | A Review on Bioactive Anthraquinone and Derivatives as the Regulators for ROS. | Molecules | 2023 | https://conductscience.org/library/papers/38138627 | PubMed |
| 11 | 20735418 | 2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20735418 | PubMed |
| 12 | 37958685 | Cistanche deserticola Polysaccharide Reduces Inflammation and Aging Phenotypes in the Dermal Fibroblasts through the Activation of the NRF2/HO-1 Pathway. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37958685 | PubMed |
| 13 | 37107309 | Targeting Mitochondrial Oxidative Stress as a Strategy to Treat Aging and Age-Related Diseases. | Antioxidants (Basel) | 2023 | https://conductscience.org/library/papers/37107309 | PubMed |
| 14 | 36050306 | Lactate metabolism in human health and disease. | Signal Transduct Target Ther | 2022 | https://conductscience.org/library/papers/36050306 | PubMed |
| 15 | 38036770 | Mitophagy in human health, ageing and disease. | Nat Metab | 2023 | https://conductscience.org/library/papers/38036770 | PubMed |
| 16 | 11018072 | Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. | J Clin Invest | 2000 | https://conductscience.org/library/papers/11018072 | PubMed |
| 17 | 20078217 | The senescence-associated secretory phenotype: the dark side of tumor suppression. | Annu Rev Pathol | 2010 | https://conductscience.org/library/papers/20078217 | PubMed |
| 18 | 31968997 | Mitochondrial Superoxide Dismutase: What the Established, the Intriguing, and the Novel Reveal About a Key Cellular Redox Switch. | Antioxid Redox Signal | 2020 | https://conductscience.org/library/papers/31968997 | PubMed |
| 19 | 1962047 | Mitochondria: structure and function. | Rev Neurol (Paris) | 1991 | https://conductscience.org/library/papers/1962047 | PubMed |
| 20 | 32694798 | Lactate: the ugly duckling of energy metabolism. | Nat Metab | 2020 | https://conductscience.org/library/papers/32694798 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41897503
GET https://conductscience.org/api/papers/v1/41897503/references?page=2